Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2021-11-24, Stock:JNJ, The news for the past five days is as follows:
2021-11-17: NEWS1: U.S. administers nearly 445 mln doses of COVID-19 vaccines - CDC.NEWS2: 'There will be another pandemic' and we need to be prepared when it comes: Doctor.NEWS3: Billionaire Ray Dalio: 'Misery and turbulence' ahead after inflation hits 31-year high — here are 3 shockproof stocks he's leaning on now.NEWS4: Stocks: Travel and crypto dip, retail rallies, pharmaceuticals rise.NEWS5: Inflation and Other News for Investors.NEWS6: Dividend Stock Portfolio: 10 Stock Picks by Hedge Funds.NEWS7: Will Investors Win With Johnson & Johnson's Planned Spinoff? Here's What History Shows.
2021-11-18: NEWS1: Covid has offered up 'acceptability and acceleration' of technologies like telemedicine: Janssen Head of R&D.NEWS2: Janssen head of R&D on Johnson & Johnson split.NEWS3: 10 Dividend Stocks in Warren Buffett’s Latest Portfolio.NEWS4: 'Everyone is a little bit confused' about COVID-19 vaccine mandates and rules: Doctor.NEWS5: FDA reviews mRNA booster shots for all adults ahead of holiday travel.NEWS6: Johnson & Johnson (JNJ) Down 0.3% Since Last Earnings Report: Can It Rebound?.NEWS7: Pharma Stock Roundup: JNJ to Spin Off Consumer Unit, PFE Eyes EUA for COVID Pill.NEWS8: J&J sees potential for 14 new multibillion-dollar drugs by 2025.NEWS9: 12 Best Big Stocks To Invest In.NEWS10: Why Conglomerates Split Up.
2021-11-19: NEWS1: GOOG vs. GOOGL: Everything You Need to Know About the Google Stock Split.NEWS2: J&J Says its Drug Pipeline Is Being Underestimated.NEWS3: 3 Recent Spin-Off Stocks Worth A Spot in Your Portfolio.NEWS4: 7 Dividend Stocks to Buy for 2022 and Hold Forever.NEWS5: U.S. administers 446.3 mln doses of COVID-19 vaccines - CDC.
2021-11-22: NEWS1: Kevin O'Leary says the 'real opportunity' for Bitcoin will come from this overlooked group of investors — but he's still a big fan of blue chip dividend stocks.NEWS2: One dose of the J&J COVID-19 vaccine is ‘certainly not enough’: Doctor.NEWS3: J&J’s Push for Settlement Talks Rebuffed by Talc Cancer Victims.NEWS4: REFILE-U.S. administers 452.6 mln doses of COVID-19 vaccines - CDC.NEWS5: Cramer's Mad Money Recap 11/22: Morgan Stanley, Centene, J&J.NEWS6: How Scale Went Out of Fashion in Corporate America.NEWS7: Walgreens (WBA) to Offer COVID-19 Vaccine Booster Shots.NEWS8: COVID-19 cases and hospitalizations on the rise ahead of holiday gatherings.NEWS9: FDA Authorizes PFE & MRNA's COVID-19 Boosters for All Adults.NEWS10: Implied Volatility Surging for Johnson & Johnson (JNJ) Stock Options.NEWS11: UPDATE 1-EU says decision on J&J COVID-19 vaccine booster dose 'within weeks'.NEWS12: EU says decision on J&J COVID-19 vaccine booster dose 'within weeks'.NEWS13: 7 Stocks to Buy for Their Resistance to the 6.2% Monthly Inflation.NEWS14: First COVID vaccine doses donated by EU begin arriving in Africa- GAVI.NEWS15: Vaccine-Makers Edge Higher as Regulators OK Boosters for All Adults.
2021-11-23: NEWS1: COVID-19 vaccines have ‘proved their merit at this point’: Doctor.NEWS2: Top Analyst Reports for Johnson & Johnson, Netflix & Oracle.NEWS3: Countries pushing vaccine IP waivers ‘want to take advantage of the technology’: Fmr. U.S. Commerce Secretary.NEWS4: COVID-19: The U.S. issues advisory for travel to Europe but has no plans for a lockdown.NEWS5: COVID-19: The U.S. issues advisory for travel to Europe but has no plans for a lockdown.NEWS6: Will Investors Benefit From Johnson & Johnson's Breakup?.NEWS7: 4 Reasons Arrowhead Pharmaceuticals Could Be the Next Biotech Buyout.

Answer: Decrease